Go Pro

Barinthus Biotherapeutics (BRNS) News Today

Barinthus Biotherapeutics logo
$0.76 0.00 (0.00%)
As of 09/4/2026 04:00 PM Eastern

Barinthus Biotherapeutics Latest News

Q3 Earnings Forecast for BRNS Issued By HC Wainwright
Research Analysts Offer Predictions for BRNS Q1 Earnings
Barinthus Biotherapeutics PLC ADR BRNS
Barinthus Biotherapeutics plc Sponsored ADR
Barinthus Biotherapeutics plc (BRNS) - Yahoo Finance
William Blair Remains a Buy on Barinthus Biotherapeutics (BRNS)
Barinthus price target lowered to $6 from $7.50 at Alliance Global Partners
Barinthus announces strategic focus in I&I, provides financial update
Barinthus Biotherapeutics Appoints New Chief Scientific Officer
Arbutus and Barinthus announce new data from IM-PROVE II trial

Barinthus Biotherapeutics Media Mentions By Week

Barinthus Biotherapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BRNS
News Sentiment

1.00

0.79

Average
Healthcare
News Sentiment

Barinthus Biotherapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BRNS Articles
This Week

0

2

BRNS Articles
Average Week

Barinthus Biotherapeutics Trends on MarketBeat

This week vs. last week
Searches
1
-75%
Page Views
1,829
+38%
Get Barinthus Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRNS and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Barinthus Biotherapeutics dated 8/24/2026.
From Our Partners